Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy
- 24 December 2009
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 66 (4) , 659-667
Abstract
Colon cancer with DNA mismatch repair (MMR) defects reveals indistinguishable clinical and pathologic aspects, including better prognosis and reduced response to 5-fluorouracil (5-FU)-based chemotherapy. There has been no consensus for p53 as a prognostic marker in colorectal cancer. This study investigated the clinical implication of MSI-H/MMR-D and p53 expression in R0-resected colon cancer patients who received adjuvant oxaliplatin/5-FU/leucovorin (FOLFOX) therapy.Keywords
This publication has 30 references indexed in Scilit:
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803Journal of Clinical Oncology, 2009
- High Frequency of Microsatellite Instability in Intestinal-type Gastric Cancer in Korean PatientsThe Korean Journal of Internal Medicine, 2005
- Two colons‐two cancers: Paradigm shift and clinical implicationsJournal of Surgical Oncology, 2004
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- Investigation of the Prognostic and Predictive Value of Thymidylate Synthase, p53, and Ki-67 in Patients With Locally Advanced Colon CancerJournal of Clinical Oncology, 2002
- Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor GenesThe American Journal of Pathology, 2001
- Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal CancerNew England Journal of Medicine, 2000
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agentsOncogene, 1997
- Clues to the Pathogenesis of Familial Colorectal CancerScience, 1993